The importance of coexisting syphilitic, chlamydial, mycoplasmal, and trichomonal infections in the treatment of gonorrhea.
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002690:Chlamydia Infections / Q000150:complications* / Q000188:drug therapy; D005260:Female; D006069:Gonorrhea / Q000150:complications* / Q000188:drug therapy; D006801:Humans; D008297:Male; D009175:Mycoplasma Infections / Q000150:complications* / Q000188:drug therapy; D013587:Syphilis / Q000150:complications*; D013752:Tetracycline / Q000627:therapeutic use; D014245:Trichomonas Infections / Q000150:complications* / Q000188:drug therapy
D000900:Anti-Bacterial Agents; D013752:Tetracycline